Caspase inhibitors attenuate superantigen-induced inflammatory cytokines, chemokines, and T-Cell proliferation

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 3, 2004, Pages 621-624

  Krakauer, Teresa ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLTYROSYLVALYLALANYLASPARTYL CHLOROMETHYL KETONE; BENZYLOXYCARBONYLASPARTYL (2,6 DICHLOROBENZOYL)OXYMETHANE; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 8; CASPASE INHIBITOR; CHEMOKINE; CYTOKINE; DNA FRAGMENT; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RECOMBINANT INTERLEUKIN 6; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; STAPHYLOCOCCUS EXOTOXIN; SUPERANTIGEN; TOXIC SHOCK SYNDROME TOXIN 1; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SEPTIC SHOCK; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

AMINO ACID CHLOROMETHYL KETONES; ASPARTIC ACID; BACTERIAL TOXINS; CASPASES; CELL PROLIFERATION; CHEMOKINE CCL2; CHEMOKINES; CYSTEINE PROTEINASE INHIBITORS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTEROTOXINS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; LEUKOCYTES, MONONUCLEAR; MACROPHAGE INFLAMMATORY PROTEIN-1; OLIGOPEPTIDES; SUPERANTIGENS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2442689243     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.3.621-624.2004     Document Type: Article

References (21)

1. Alam, A., L. Y. Cohen, S. Aouad, and R. P. Sekaly. 1999. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 190:1879-1890.
2. Bergdoll, M. S., and P. M. Schlievert. 1984. Toxic shock syndrome toxin. Lancet 11:691.
3. Cameron, S. B., M. C. Nawijn, W. W. Kum, H. F. Savelkoul, and A. W. Chow. 2001. Regulation of helper T cell responses to staphylococcal superantigens. Eur. Cytokine Netw. 12:210-222.
4. Choi, Y., B. Kotzin, L. Hernon, J. Callahan, P. Marrack, and J. Kappler. 1989. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc. Natl. Acad. Sci. USA 86:8941-8945.
5. Cohen, G. M. 1997. Caspases: the executioners of apotosis. Biochem. J. 326:1-16.
6. Garcia-Calvo, M., E. P. Peterson, B. Leiting, R. Ruel, D. W. Nicholson, and N. A. Thornberry. 1998. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273:32608-32613.
7. Iwata, A., K. Nishio, R. K. Winn, E. Y. Chi, W. R. Henderson, Jr., and J. M. Harlan. 2003. A broad-spectrum caspase inhibitor attenuates allergic airway inflammation in murine asthma model. J. Immunol. 170:3386-3391.
8. Kennedy, N. J., T. Kataoka, J. Tschopp, and R. C. Budd. 1999. Caspase activation is required for T cell proliferation. J. Exp. Med. 190:1891-1896.
9. Kotzin, B. L., D. Y. M. Leung, J. Kappler, and P. A. Marrack. 1993. Superantigens and their potential role in human disease. Adv. Immunol. 54:99-166.
10. Krakauer, T. 1994. Inhibition of toxic shock syndrome toxin-1-induced cytokine production and T cell activation by interleukin-10, interleukin-4, and dexamethasone. J. Infect. Dis. 172:988-992.
11. Krakauer, T. 1999. Induction of CC chemokines in human peripheral blood mononuclear cells by staphylococcal exotoxins and its prevention by pentoxifylline. J. Leukoc. Biol. 66:158-164.
12. Krakauer, T., J. Vilcek, and J. J. Oppenheim. 1998. Proinflammatory cytokines: TNF and IL-1 families, chemokines, TGFβ and others, p. 775-811. In W. Paul (ed.), Fundamental immunology, 4th ed. Lippincott-Raven Press, Philadelphia, Pa.
13. Kunstle, G., M. Leist, S. Uhlig, L. Revesz, R. Feifel, A. MacKenzie, and A. Wendel. 1997. ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha. Immunol. Lett. 55:5-10.
14. Kuwano, K., R. Kunitake, T. Maeyama, N. Hagimoto, M. Kawasaki, T. Matsuba, M. Yoshimi, I. Inoshima, K. Yoshida, and N. Hara. 2001. Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:L316-L325.
15. McCormick, J. K., J. M. Yarwood, and P. M. Schlievert. 2001. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 55:77-104.
16. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P. H. Krammer, and H. Wagner. 1992. T cell-mediated lethal shock triggered in mice by the superantigen SEB: critical role of TNF. J. Exp. Med. 175:91-98.
17. Mukerjee, N., K. M. McGinnis, M. E. Gnegy, and K. K. Wang. 2001. Caspase-mediated calcineurin activation contributes to IL-2 release during T cell activation. Biochem. Biophys. Res. Commun. 285:1192-1199.
18. Paszkowski, A. S., B. Rau, J. M. Mayer, P. Moller, and H. G. Beger. 2002. Therapeutic application of caspase 1/interleukin 1β-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis. Ann. Surg. 235:68-76.
19. Stevens, D. L. 1996. The toxic shock syndromes. Infect. Dis. Clin. N. Am. 10:727-746.
20. Talanian, R. V., C. Quinlan, S. Trautz, M. C. Hackett, J. A. Mankovich, D. Banach, T. Ghayur, K. D. Brady, and W. W. Wong. 1997. Substrate specificities of caspase family proteases. J. Biol. Chem. 272:9677-9682.
21. Zeuner, A., A. Eramo, C. Peschle, and R. De Maria. 1999. Caspase activation without death. Cell Death Differ. 6:1075-1080.